Professional perspective on a feasibility study of GP-pharmacist collaboration in the management of angina

International Journal of Pharmacy Practice

Volumn 8, Issue 4, 2000, Pages 275-284

  Ryan Woolley, B M ^a   Cantrill, J A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGINA PECTORIS; ARTICLE; DIET; EVIDENCE BASED MEDICINE; EXERCISE; FEASIBILITY STUDY; GENERAL PRACTITIONER; HUMAN; ISCHEMIC HEART DISEASE; JOB SATISFACTION; MAJOR CLINICAL STUDY; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SMOKING CESSATION; UNITED KINGDOM;

EID: 0034500038     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2000.tb01016.x     Document Type: Article

References (33)

1. Prevention of coronary heart disease in clinical practice. Recommendations of the task force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
2. Managing established coronary heart disease
3. Use of aspirin in secondary prevention of coronary heart disease is rising
4. Adherence to cardiac rehabilitation guidelines: A survey of cardiac rehabilitation programmes in the United Kingdom
5. Preventive care for patients following myocardial infarction
6. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (action on secondary prevention through intervention to reduce events)
7. Preventing recurrent coronary heart disease
8. Wiltshire pharmacy health promotion training initiative: A telephone survey
9. Smoking cessation, nicotine replacement and community pharmacy
10. Pharmacists are key members of the primary health care team
11. A controlled evaluation of the effect of community pharmacists on general practitioner prescribing
12. An evaluation of the effectiveness of community pharmacists working with GPs to increase the cost-effectiveness of prescribing
13. Long-term effect on mortality of stopping smoking after unstable angina and myocardial infarction
14. Can lifestyle changes reverse coronary disease? The lifestyle heart trial
15. Trends in coronary heart disease mortality and fat consumption in the United States between 1909 and 1980
16. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction; diet and reinfarction trial (DART)
17. An overview of randomised trials of rehabilitation with exercise after myocardial infarction
18. Collaborative overview of randomised trials of antiplatelet therapy 1. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
19. For the Swedish Angina Pectoris Aspirin Trial Group: Double blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris
20. Overview of results of randomised clinical trials in heart disease: Treatment following myocardial infarction
21. Randomised trial of cholesterol lowering in 4444 patients with coronary artery disease: The Scandinavian Simvastatin Survival Study (4S)
22. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. The Cholesterol and Recurrent Events (CARE) Trial
23. Towards a comprehensive model of change
24. Grading of angina pectoris [letter]
25. Doctors resist pharmacist prescribing
26. Crown fails to establish case for pharmacy prescribing, says BMA
27. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk
28. Cardiac rehabilitation guidelines and audit standards